<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134325">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01702779</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0107</org_study_id>
    <nct_id>NCT01702779</nct_id>
  </id_info>
  <brief_title>Nasal Humidified High Flow Oxygen During Weaning From Mechanical Ventilation : Ultrasonography Study</brief_title>
  <acronym>HiFloLUS</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ICU Viars, Pitié-Salpétrière Hospital, Paris, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized clinical multicentric study in ICU (Intensive Care
      University)during weaning from mechanical ventilation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective randomized clinical multicentric study on ICU (Intensive Care University)
      comparing nasal humidified high flow therapy versus standard oxygen with Lung Ultrasound
      Score during weaning from mechanical ventilation
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>variations of lung ultrasound score</measure>
    <time_frame>24 hours after extubation</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung ultrasound score</measure>
    <time_frame>at baseline, 4-6 hours after extubation, 24 hours after extubation, 48 hours after extubation</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rates of patients with postextubation distress</measure>
    <time_frame>during the 48th post-extubation</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrical Impedance tomography</measure>
    <time_frame>at baseline, 4-6 hours after extubation, 24 hours after extubation, 48 hours  after extubation</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epithelial and endothelial biomarkers</measure>
    <time_frame>at baseline, 4-6 hours after extubation, 24 hours after extubation, 48 hours after extubation</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Adult Patients Ventilated More Than 48 h</condition>
  <condition>Stable Respiratory and Hemodynamic Conditions for SBT</condition>
  <condition>Consent of Patients</condition>
  <condition>Arterial Line</condition>
  <arm_group>
    <arm_group_label>optiflow</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>O2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>mechanical ventilation</intervention_name>
    <description>Prospective, randomized clinical multicentric study in ICU (Intensive Care University)during weaning from mechanical ventilation.</description>
    <arm_group_label>optiflow</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>mechanical ventilation</intervention_name>
    <description>Prospective, randomized clinical multicentric study in ICU (Intensive Care University)during weaning from mechanical ventilation.</description>
    <arm_group_label>O2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients ventilated more than 48 h

          -  Stable respiratory and hemodynamic conditions for SBT

          -  Consent of patients

          -  Arterial line

        Exclusion Criteria:

          -  COBP

          -  Laryngeal dyspnea

          -  Tracheostomy

          -  Arythmya

          -  No echogenicity

          -  Paraplegia &gt;T8
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sébastien PERBET</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>04 73 75 11 95</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick LACARIN</last_name>
      <phone>04 73 75 11 95</phone>
      <email>placarin@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>October 5, 2012</lastchanged_date>
  <firstreceived_date>April 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Weaning from mechanical ventilation</keyword>
  <keyword>Lung ultrasound</keyword>
  <keyword>Oxygen inhalation therapy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
